News Details

Brazil is considering Bill PL 3169/2026, which would introduce mandatory labelling of products intended for babies, children and pregnant women when they contain chemicals identified by the competent health authority as having endocrine-disrupting potential. The proposal also establishes a transition period before restrictions on the manufacture, import, distribution, sale and offering of specified products containing these substances would apply. 

Key provisions 

• Labelling requirements: Products covered by the proposal would need clear and visible information indicating the presence of identified endocrine-disrupting substances. 

• Products covered: Cosmetics and personal-care products, including shampoos, soaps, sunscreens, insect repellents, lotions and creams intended for babies, children and pregnant women. The proposal also covers food packaging for infant food, children's products such as toys and feeding utensils, and medicines. 

• Regulatory criteria: The government would establish technical criteria for identifying endocrine disruptors, labelling requirements and procedures for periodically updating the list of identified substances. 

• Restrictions after transition: Five years after the law enters into force, the manufacture, import, distribution, sale and offering of covered products containing substances identified for restriction would be prohibited, subject to regulatory tolerance limits and conditions. 

• Medicines: Restrictions would follow a specific regime based on a risk-benefit assessment and would apply only when an effective and safe alternative treatment without the substance is available. 

Important timelines 

• 17 June 2026: Bill PL 3169/2026 introduced. 

• On publication: The law would enter into force. 

• Within six months of publication: The government would be required to issue implementing regulations. 

• At least 18 months before the end of the five-year transition period: Regulations specifying the substances subject to restrictions, applicable tolerance limits, technical assessment conditions, the transition schedule and substitution requirements would have to be published. 

• Five years after entry into force: The proposed restrictions would take effect. 

The labelling obligation would apply during the transition period and continue thereafter for substances that are not prohibited. 

Current status and industry relevance 

The bill remains under review in Brazil’s Chamber of Deputies and is awaiting the appointment of a rapporteur in the Health Committee. It has not yet become law. 

Cosmetics manufacturers, importers and suppliers of personal-care products intended for babies, children and pregnant women should monitor the proposal for potential future labelling and substance-restriction requirements. The specific substances and applicable limits would be established through subsequent regulations.